The influence of histologic subtype on toxicity and response to chemotherapy in non-Hodgkin-s lymphoma an eastern cooperative oncology group study utilizing the BCVP regimen
- 1 May 1983
- Vol. 51 (9), 1581-1586
- https://doi.org/10.1002/1097-0142(19830501)51:9<1581::aid-cncr2820510905>3.0.co;2-l
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma a progress reportCancer, 1980
- Non-Hodgkin's Lymphoma — Selection of Treatment on the Basis of Histologic TypeNew England Journal of Medicine, 1979
- Chemotherapy of advanced non-Hodgkin's lymphomaClinics in Haematology, 1979
- Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group studyCancer, 1979
- Treatment of histiocytic and mixed lymphomas.A comparison of two, three and four drug chemotherapyCancer, 1978
- Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphomaBlood, 1977
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- 1.3‐Bis(2‐chloroethyl)‐1‐nitrosourea(BCNU), cyclophosphamide, vincristine‐ and prednisone‐(BCOP): A new therapeutic regimen for diffuse histiocytic lymphomaCancer, 1975
- Combination Chemotherapy of Lymphomas Other Than Hodgkin's DiseaseAnnals of Internal Medicine, 1974
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972